{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:29:05Z","timestamp":1788780545314,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018890","name":"Dutch Cardiovascular Alliance","doi-asserted-by":"publisher","award":["01\\u2013002-2022\\u20130118 EmbRACE"],"award-info":[{"award-number":["01\\u2013002-2022\\u20130118 EmbRACE"]}],"id":[{"id":"10.13039\/100018890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["848090001"],"award-info":[{"award-number":["848090001"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["945260"],"award-info":[{"award-number":["945260"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijcha.2025.101700","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T14:52:09Z","timestamp":1746802329000},"page":"101700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Multimorbidity increases risk of atrial fibrillation recurrence after cryoballoon ablation"],"prefix":"10.1016","volume":"59","author":[{"given":"Marieke J.H.","family":"Velt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colinda","family":"van Deutekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lobeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Rienstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Blaauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart A.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcha.2025.101700_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.ijcha.2025.101700_b0010","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Europ. Heart J. 2024."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101700_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"EP Europace."},{"key":"10.1016\/j.ijcha.2025.101700_b0020","article-title":"Managing elderly patients with atrial fibrillation and multimorbidity: call for a systematic approach","volume":"1\u201314","author":"van Deutekom","year":"2024","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101700_b0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/eurheartj\/ehx466","article-title":"Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study","volume":"39","author":"Pallisgaard","year":"2017","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101700_b0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1540-8167.2008.01101.x","article-title":"Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence","volume":"19","author":"Shah","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101700_b0035","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/eurheartj\/ehm027","article-title":"Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation","volume":"28","author":"Berruezo","year":"2007","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101700_b0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/europace\/eun309","article-title":"Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation","volume":"11","author":"Letsas","year":"2008","journal-title":"EP Europace."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101700_b0045","first-page":"164","article-title":"Impact of Uncontrolled Hypertension onAtrial Fibrillation Ablation Outcome","volume":"1","author":"Santoro","year":"2015","journal-title":"JACC: Clin. Electrophysiol."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101700_b0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/pace.13311","article-title":"Uncontrolled blood pressure affects atrial remodeling and adverse clinical outcome in paroxysmal atrial fibrillation","volume":"41","author":"Kamioka","year":"2018","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101700_b0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jce.13388","article-title":"Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients","volume":"29","author":"Sivasambu","year":"2018","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101700_b0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/heartjnl-2018-313490","article-title":"Impact of body mass index on the outcome of catheter ablation of atrial fibrillation","volume":"105","author":"Glover","year":"2019","journal-title":"Heart"},{"issue":"20","key":"10.1016\/j.ijcha.2025.101700_b0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012253","article-title":"Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study","volume":"8","author":"Provid\u00eancia","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101700_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/1087623","article-title":"Impact of diabetes mellitus on atrial fibrillation recurrence and major adverse cardiac and cerebrovascular events following catheter ablation","volume":"2024","author":"Lin","year":"2024","journal-title":"Int. J. Clin. Pract."},{"issue":"21","key":"10.1016\/j.ijcha.2025.101700_b0075","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.3390\/jcm10214863","article-title":"The effect of diabetes mellitus on the recurrence of atrial fibrillation after ablation","volume":"10","author":"Guckel","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101700_b0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2019.12.037","article-title":"Impact of type-2 diabetes mellitus on the outcomes of catheter ablation of atrial fibrillation (European observational multicentre study)","volume":"125","author":"Creta","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101700_b0085","first-page":"897","article-title":"Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrialfibrillation ablation","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC: Clinical Electrophysiology."},{"key":"10.1016\/j.ijcha.2025.101700_b0090","doi-asserted-by":"crossref","unstructured":"Younis A, Tabaja C, Santangeli P, Nakagawa H, Sipko J, Madden R, et al. Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes. Circulation: Arrhythm. Electrophysiol. 2024;17(9) e012926.","DOI":"10.1161\/CIRCEP.124.012926"},{"issue":"20","key":"10.1016\/j.ijcha.2025.101700_b0095","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/01.CIR.0000068337.25994.21","article-title":"Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation","volume":"107","author":"Kanagala","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101700_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002315","article-title":"Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort","volume":"10","author":"Van Deutekom","year":"2023","journal-title":"Open Heart."},{"key":"10.1016\/j.ijcha.2025.101700_b0105","unstructured":"van Deutekom C, Weil LI, Samuel M, Geelhoed B, Velt MJH, Middeldorp ME, et al. Multimorbidity and risk of atrial fibrillation in the Lifelines Cohort. [Manuscript submitted for publication]."},{"key":"10.1016\/j.ijcha.2025.101700_b0110","doi-asserted-by":"crossref","unstructured":"C. van Deutekom M.E. van de Lande R. Rama B.-O. Nguyen R.G. Tieleman V. Webernd\u00f6rfer et al. Multimorbidity is associated with symptom severity and disease progression in patients with paroxysmal atrial fibrillation - Data from the RACE V study Manuscript Accepted for Publication 2024.","DOI":"10.1161\/JAHA.123.034514"},{"key":"10.1016\/j.ijcha.2025.101700_b0115","doi-asserted-by":"crossref","unstructured":"Jani BD, Nicholl BI, McQueenie R, Connelly DT, Hanlon P, Gallacher KI, et al. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace. 2018;20(Fi_3):f329-f36.","DOI":"10.1093\/europace\/eux322"},{"key":"10.1016\/j.ijcha.2025.101700_b0120","doi-asserted-by":"crossref","unstructured":"Kotalczyk A, Guo Y, Wang Y, Lip GYH, Investigators obotCR. Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation. J. Clin. Med. 2022;11(5):1370.","DOI":"10.3390\/jcm11051370"},{"key":"10.1016\/j.ijcha.2025.101700_b0125","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-024-03007-9","article-title":"Clinical outcomes of patients with atrial fibrillation in relation to multimorbidity status changes over time and the impact of ABC pathway compliance: a nationwide cohort study","author":"Krittayaphong","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcha.2025.101700_b0130","unstructured":"van Deutekom C, Velt MJH, van Gelder IC, Rienstra M, Mulder BA. Multimorbidity increases risk of Cardiovascular Outcomes in Permanent Atrial Fibrillation: Data from the RACE II study. [Manuscript submitted for publication]."},{"issue":"10","key":"10.1016\/j.ijcha.2025.101700_b0135","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/pace.13763","article-title":"Influence of risk factors in the ESC-EHRA EORP atrial fibrillation ablation long-term registry","volume":"42","author":"Trines","year":"2019","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcha.2025.101700_b0140","article-title":"Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3\u00b74 million individuals. The Lancet Regional Health","volume":"17","author":"Wu","year":"2022","journal-title":"Europe"},{"key":"10.1016\/j.ijcha.2025.101700_b0145","article-title":"The atrial fibrillation burden during the blanking period is predictive of time to recurrence after catheter ablation","volume":"43","author":"Silva Cunha","year":"2022","journal-title":"IJC Heart Vasc."},{"issue":"21","key":"10.1016\/j.ijcha.2025.101700_b0150","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome ofablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101700_b0155","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jce.14607","article-title":"Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation","volume":"31","author":"Donnellan","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"19","key":"10.1016\/j.ijcha.2025.101700_b0160","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCULATIONAHA.116.026230","article-title":"Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation","volume":"135","author":"Parkash","year":"2017","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ijcha.2025.101700_b0165","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jacc.2012.05.036","article-title":"A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension","volume":"60","author":"Pokushalov","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101700_b0170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients With paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.ijcha.2025.101700_b0175","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcha.2025.101700_b0180","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"EP Europace."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:18:01Z","timestamp":1762622281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"alternative-id":["S2352906725001034"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101700","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimorbidity increases risk of atrial fibrillation recurrence after cryoballoon ablation","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101700"}}